Business
Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA | BSE: 543635), is pleased to announce the successful development, scale-up, and commercialization of a tablet-in-capsule drug delivery system at its drug product facilities in Pithampur and Ahmedabad, India. With expanded tablet-in-capsule capabilities now in its toolkit, Piramal can offer partners and patients more flexible and customizable dosin
About this update from Piramal Pharma Limited
[{"type":"list","items":[{"val":[{"type":"text","content":"Piramal Pharma Solutions continues to lead its advanced dosage form expertise by successfully developing and commercializing a tablet-in-capsule product across its integrated drug product sites in Pithampur and Ahmedabad, India.","length":228,"tagName":"p"}]},{"val":[{"type":"text","content":"The project involved seamless technology transfer and close collaboration between both site teams, highlighting the strength of Piramal's integrated capabilities.","length":171,"tagName":"p"}]},{"val":[{"type":"text","content":"By implementing tablet-in-capsule capabilities, Piramal reinforces its commitment to Patient Centricity. ","length":109,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":508,"olType":false},{"type":"text","content":"MUMBAI, India, Feb. 2, 2026 /PRNewswire/ -- Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA | BSE: 543635), is pleased to announce the successful development, scale-up, and commercialization of a tablet-in-capsule drug delivery system at its drug product facilities in Pithampur and Ahmedabad, India. With expanded tablet-in-capsule capabilities now in its toolkit, Piramal can offer partners and patients more flexible and customizable dosing options for critical oral drug therapies, including modified release drug delivery.","length":629,"tagName":"p"},{"type":"image","alt":"Brad Gold, Ph.D., Head of Global Formulations R and D, Piramal Pharma Solutions","displaySize":"","headline":null,"caption":"Brad Gold, Ph.D., Head of Global Formulations R and D, Piramal Pharma Solutions","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/3b5d83706e62e38cd0d2dd7b6f745dca"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/aJPAzpdD0Gw6eQOj9PwbcA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/3b5d83706e62e38cd0d2dd7b6f745dca","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2874815/Piramal_Pharma_Solutions_Brad_Gold.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The project was initiated at the Piramal Pharmaceutical Development Services (PPDS) site in Ahmedabad. Within just five months, the...